Shares of CERo Therapeutics Holdings, Inc. (NASDAQ:CERO – Get Free Report) dropped 5.5% on Thursday . The stock traded as low as $0.24 and last traded at $0.25. Approximately 1,109,603 shares were traded during trading, a decline of 61% from the average daily volume of 2,870,009 shares. The stock had previously closed at $0.27.
CERo Therapeutics Stock Down 5.5 %
The stock has a 50-day moving average of $0.83.
CERo Therapeutics Company Profile
CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
Featured Articles
- Five stocks we like better than CERo Therapeutics
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- Most active stocks: Dollar volume vs share volume
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Ride Out The Recession With These Dividend Kings
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for CERo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CERo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.